This was also the case in the BRIDGE study whereby 9 patients out of 864 with either idiopathic PAH or hereditary PAH had bi-allelic EIF2AK4 mutations [5]. The gene discussed is EIF2AK4; the disease is pulmonary arterial hypertension.